LinkedIn image ad examples

Presenting at the ESMO Annual Meeting? Extend your impact by publishing in JCO Journals and reaching oncologists worldwide. Our Fast Track, Rapid Review, and format-free EZ Submit support a streamlined submission process.

Send us 100 paid charts and their 835s. In one business day, see what ClaimReady predicted each would pay — next to what the payer actually paid.

What if chasing your goals is one of the best things you can show your kids? Early in her career, Stefani Klaskow always felt “overwhelming mom guilt, as if excelling at work meant failing at home.” Then she realized the opposite was true. “Living a full, ambitious life wasn’t taking away from my children. It was modeling for them, especially my daughter, what an independent, multifaceted woman looks like.” Careers come with rules no one ever voted on or agreed to. We asked women we admire to share one unwritten rule they inherited and give it a rewrite. Stefani Klaskow, Managing Director, Health at Google, rewrote this one: ❌ Succeed at work, but never at the expense of your personal life. ✅ Pursue the work that fulfills you. Showing your kids how to build a meaningful life is a gift. What’s one “rule” you’re done following? Learn more about the Permission Project 👉 https://lnkd.in/gxRWc27U #PermissionProject #WeBelieveInBetter #UnwrittenRules #WBIB #MentalHealthMatters

Katie Horwitch used to feel nauseous asking for help. Then she realized that letting people help you can be an act of generosity too. “People often love being useful, and letting them show up turns life into a group project instead of something we're all supposed to figure out alone.” Every career comes with rules no one ever agreed to. So we asked women we admire to share an unwritten rule that slipped into their lives without their permission, and rewrite it into what they believe now. Katie Horwitch, author, mindset coach, and founder of WANT: Women Against Negative Talk, rewrote this one: ❌ Ask for help, but don’t be a burden. ✅ Letting people help you creates connection. What’s one inherited rule you’re ready to rewrite? Tell us in the comments 👇 Download the free Rewrite Guide 👉 https://lnkd.in/gxRWc27U #PermissionProject #WeBelieveInBetter #UnwrittenRules #WBIB #MentalHealthMatters

Anatomy, workflow and evidence come together in pulmonary valve care. Explore the therapy and delivery-system overview. ⬇️

Already sequencing microbiome samples? Add the reporting layer. For laboratories looking to expand their microbiome offering, myBioma provides more than a consumer testing solution. Our technology can integrate with existing laboratory workflows, enabling partners to combine their own sequencing capabilities with myBioma’s microbiome analysis and digital reporting infrastructure. During our Black Month, we're opening a limited onboarding window for selected new White Label partners, with preferential conditions and discounts available throughout the campaign. Turn sequencing data into a complete microbiome product, without developing the entire reporting ecosystem internally.

Your microbiome test. Your brand. Our infrastructure. Launching a branded microbiome solution doesn’t have to mean building the science, laboratory processes, bioinformatics and digital reporting from scratch. With myBioma White Label, health and wellness companies can integrate advanced microbiome testing into their existing portfolio under their own brand. During our Black Month, we're opening a limited onboarding window for selected new White Label partners, with preferential conditions and discounts available throughout the campaign. If microbiome testing is part of your growth strategy, now is the time to explore what a partnership could look like.

Clinical evaluation is the most underestimated challenge in your MDR compliance journey. Most manufacturers focus heavily on QMS documentation and technical files. But it's your clinical evaluation that often becomes the bottleneck. Why? Because it requires both scientific rigor and regulatory precision. And notified bodies are scrutinizing this area more than ever before. The stakes are clear: insufficient clinical data means delayed market access or even rejection. So what does a compliant clinical evaluation actually look like? Here are 5 essential elements every MedTech leader needs to master: Clinical Evaluation Plan (CEP) ↳ This isn't just a document. It's your roadmap for success. ↳ Define specific endpoints that align with your intended purpose. ↳ Remember that vague objectives lead to undefined outcomes. Literature Review Strategy ↳ Simply collecting studies isn't enough anymore. ↳ You need a systematic search methodology with clear inclusion/exclusion criteria. ↳ Document why certain studies were rejected, auditors always ask this. Clinical Data Sufficiency ↳ "Sufficient" clinical data is subjective until you define it. ↳ Create a clear threshold for what constitutes adequate evidence. ↳ Pre-MDR data often falls short of current expectations. Post-Market Clinical Follow-Up (PMCF) ↳ This isn't optional. It's a fundamental part of your clinical evaluation. ↳ Notified bodies expect proactive data collection, not just passive surveillance. ↳ The days of "we have no complaints" as sufficient PMCF are long gone. Equivalence Justification ↳ The bar for equivalence has been raised significantly under MDR. ↳ You need access to technical documentation of equivalent devices. ↳ Without contractual agreements, equivalence claims are increasingly difficult to defend. Clinical evaluation isn't a one-time task. It's a continuous process throughout your device's lifecycle. The manufacturers who succeed are those who integrate clinical thinking from design phase through post-market surveillance. P.S. What's been your biggest challenge with clinical evaluations under MDR? ⬡⬡⬡⬡⬡⬡⬡⬡⬡⬡⬡⬡⬡⬡⬡⬡⬡⬡⬡⬡⬡⬡⬡⬡⬡⬡⬡⬡⬡⬡⬡⬡⬡⬡⬡⬡⬡⬡⬡⬡⬡⬡ MedTech regulatory challenges can be complex, but smart strategies, cutting-edge tools, and expert insights can make all the difference. I'm Tibor, passionate about leveraging AI to transform how regulatory processes are automated and managed. Let's connect and collaborate to streamline regulatory work for everyone! #automation #regulatoryaffairs #medicaldevices

🪴 Πώς μπορούμε να διαμορφώσουμε ένα πιο ανθεκτικό μέλλον για την ευρωπαϊκή γεωργία; Η απάντηση βρίσκεται στην επιστήμη, την καινοτομία και την πρόσβαση των αγροτών σε σύγχρονες τεχνολογίες. Σύμφωνα με νέα έκθεση της Bayer, που συνδυάζει οικονομική ανάλυση της Oxford Economics και έρευνα σε περισσότερους από 8.000 καταναλωτές, η ευρωπαϊκή γεωργία βρίσκεται αντιμέτωπη με σημαντικές προκλήσεις που επηρεάζουν την παραγωγικότητα και την ανταγωνιστικότητά της. 📊 Το 84% των Ευρωπαίων καταναλωτών θεωρεί ότι οι αγρότες πρέπει να έχουν πρόσβαση στις πιο σύγχρονες τεχνολογίες και καινοτομίες. Στην Bayer, πιστεύουμε στη δύναμη της επιστήμης να συμβάλλει σε ένα μέλλον όπου οι αγρότες θα έχουν περισσότερες δυνατότητες και η γεωργία θα γίνεται πιο ανθεκτική, παραγωγική και βιώσιμη. 🔗 Μάθε περισσότερα: https://lnkd.in/dRGvMJcA

Join us on November 3, 2026, for the first webinar in our free live series: From hands-on to walk-away – Finding the right level of automation for your lab Join our experts for a practical, approachable look at where automation can add value in your lab. Together, we will explore how to assess your workflow, identify meaningful opportunities for automation, and choose an approach that fits the way your team works. Why attend? • Save time on repetitive pipetting and focus more on your experiments and results. • Process more samples consistently with less manual variability. • Reduce the risk of errors in routine liquid-handling workflows. • Understand when automation adds value and what it involves. • Choose the right platform for your lab and workflow. 📅 November 3, 2026 | 4:00 p.m. CET Join us live and bring your questions about laboratory automation.

🛒 Shop now: www.periocream.com Dentists, periodontists & dental hygienists — discover our Swiss-made mucoadhesive periodontal paste, designed to provide a long-lasting protective barrier and improve patient comfort after SRP. ✅ Order your box of 6 syringes today for just €150!

Vil du blive skarpere på behandling af slidte tænder? På F.I.T.-kurset i Aarhus får du indsigt i Forma Injektion Teknik, gennemgang af kliniske cases og mulighed for selv at afprøve teknikken i praksis. Du får ikke kun teori – du får praktisk erfaring og et workflow, du kan arbejde videre med i din egen klinik. 📅 28. oktober 2026 | 📍 Aarhus Sikr din plads i dag! 👉 Tilmeld dig her:

Inovar em saúde envolve transformar conhecimento científico em aplicações que contribuam para a investigação de doenças e as decisões de cuidado. Na medicina nuclear, a integração entre radiofármacos e tecnologias de imagem permite avaliar processos biológicos no organismo, complementando as informações disponíveis para a equipe médica. Esse avanço resulta de pesquisa, desenvolvimento e colaboração entre diferentes áreas. A CMR Pharma participa desse ecossistema com a produção de radiofármacos para a medicina nuclear. Em 19 de outubro, Dia Nacional da Inovação, reconhecemos o trabalho que conecta ciência à prática em saúde. #CMRPharma #DiaNacionalDaInovação #MedicinaNuclear #ImagemMolecular

Ambient scribe technology is being adopted quickly across healthcare systems, and for good reason. It takes note-taking and paperwork off the doctor during the consultation, so they can keep their attention on the patient in front of them rather than on a screen. More eye contact, less admin, more patients seen. It is a genuine improvement to the visit, and I am glad it is happening. But it also does not touch the part of the problem that matters most. The doctor visit lasts a few minutes. The rest of the year, the roughly 364 days the patient is not sitting in that room, is where the disease is managed, and an in-visit tool was never built to reach it. The reason this is worth saying out loud is that it is easy to adopt the scribe, feel the improvement, and assume the gap is now covered. Closing that gap means taking the signal patients generate at home and getting it into the same place the scribe already feeds the clinical workflow. The doctor walks into the visit already seeing what happened in the weeks before it. That is where the ambient scribe becomes more than a time-saver. It becomes the shared layer that carries patient signal into the EHR without a custom build at every hospital and the other 364 days finally reach the people making the decisions. Now that the scribe is being adopted so widely, who is already treating it this way, rather than just as a better way to document the visit?

Wie individuell sollte High-Flow-Sauerstofftherapie sein? Jeder Patient bringt unterschiedliche Voraussetzungen, Krankheitsverläufe und Therapieziele mit. Deshalb sollte sich nicht der Patient an die Therapie anpassen müssen, sondern die Therapie an den Patienten. Moderne HFOT-Lösungen müssen flexibel genug sein, um unterschiedliche Patientenpopulationen, Sauerstoffbedarfe und klinische Anforderungen zu unterstützen. Der HAMILTON-HF90 wurde entwickelt, um genau diese Flexibilität im klinischen Alltag bereitzustellen. 👉 Welche Anforderungen stellen Ihre Patienten am häufigsten an die HFOT? Lernen Sie den HAMILTON-HF90 im Gespräch mit einem unserer High-Flow-Experten näher kennen: https://okt.to/a9EnVe #HighFlowOxygenTherapy #HFOT #HamiltonMedical #HAMILTONHF90

Heading to ASHG 2026 in Montréal (October 20–24)? Come explore GAIA with us at Booth 311. Geneyx is a multi-agentic platform for analysis and interpretation of multiomics data, helping clinical and research organizations turn complex sequencing data into actionable insights. At the booth, you'll see: • GAIA, the Geneyx AI suite for genetic analysis A live demo of how GAIA harnesses AI across the workflow, from variant prioritization to reporting. • PacBio integration Our integration with PacBio's secondary analysis pipeline, for an end-to-end long-read genomics workflow, from raw data to interpretation. • MultiOmics expansion How Geneyx takes you from short- and long-read data to multiomics analysis, with DNA, RNA and methylation evidence in a single interpretation workflow. Meet our team at the booth: Willem Haagmans, VP Global Sales Eli Sward, PhD, Associate Director, Field Application Specialist Dana Odenbeck, Commercial Director Want to make sure we have time for you? Reply to this email to book a meeting or bring your toughest case and stop by. 📍 Booth 311 | ASHG Annual Meeting, Montréal | October 20–24, 2026 See you in Montréal!

🏡 Votre maison de repos est-elle prête pour l'enregistrement obligatoire des temps de travail ? Inscrivez-vous au webinaire gratuit et découvrez-le.

Bajo el lema “De la ciencia al paciente, salud sin distancias” el Congreso de la Sociedad Española de Farmacia Hospitalaria (SEFH) reunirá a profesionales de la Farmacia Hospitalaria para compartir conocimiento y abordar algunos de los principales retos de la especialidad. Como cada año, Fresenius Kabi estará presente en el stand formando parte de este punto de encuentro entre ciencia, práctica clínica y profesionales del sector. Una cita para seguir cerca de quienes trabajan cada día por avanzar en la atención al paciente. 📅 21-23 de octubre de 2026 📍 Plaza de las convenciones, Gran Canaria, Las Palmas ¡Nos vemos en el stand 19 y 20 de Fresenius Kabi!

🌿 Phytochemistry & Innovation: Arnicolide C, the key active component of Centipeda minima 👉 While Arnica montana remains the European benchmark for sesquiterpene lactones, Arnicolide C is present in it only as a minor trace compound. To unlock the full pharmacological potential of this molecule, research turns to traditional Asian pharmacopeia and Centipeda minima (鹅不食草 - Eshi Cao). 👉 Unlike Arnica species, Centipeda minima offers a high concentration of Arnicolide C, making it its primary phytochemical marker and the main driver of its biological activities. 🔬 An outstanding pharmacological profile 🔎 Recent studies highlight targeted mechanisms of action for Arnicolide C: 1️⃣ Anti-inflammatory & anti-allergic action: Inhibition of the NF-κB and JAK/STAT signaling pathways, decreasing the secretion of pro-inflammatory cytokines (TNF-alpha, IL-6) - providing scientific validation for its traditional use in allergic rhinitis and ENT congestion. 2️⃣ Antiproliferative potential: Modulation of the PI3K/Akt axis and induction of apoptosis via the mitochondrial pathway, positioning this compound as a promising candidate in experimental oncology. 3️⃣ Dermo-pharmacological activity: Regulation of keratinocyte proliferation, opening therapeutic avenues for targeted skin care applications (soothing care, psoriasis). 🎯 Quality control with Extrasynthese reference standard 👍 To guarantee the compliance, traceability, and reproducibility of Centipeda minima extracts or to conduct rigorous bioactivity studies (in vitro and in vivo), utilizing a purified analytical standard is essential. 🔗 https://lnkd.in/eD5trbSf Extrasynthese provides Arnicolide C as a certified reference substance: ✅ Quality control of botanical raw materials and total extracts (HPLC/LC-MS) ✅ Standardization of phytotherapeutic and cosmetic formulations ✅ Reliable benchmark for screening assays and pharmacological research 💡 Secure your analytical developments and value your plant extracts with our high-purity phytochemical standards. 🔗 Browse our catalog for your QC or R&D applications: https://lnkd.in/eP33xZEd 👉 Explore our Arnicolide C standard and complete catalog of sesquiterpene lactones on our website: https://lnkd.in/eRXGwUuf #Phytochemistry #AnalyticalChemistry #CentipedaMinima #ArnicolideC #Phytotherapy #Extrasynthese #QualityControl #ReferenceMaterials #NaturalProducts

Excelencia médica que transforma vidas 🧠Reconocemos al Dr. Eli Skromne, especialista en Enfermedades Desmielinizantes y Esclerosis Múltiple, por su nombramiento entre Los Mejores Médicos de México en la categoría de Neurología. 🏅Su trayectoria y experiencia en neurología lo distinguen como uno de los referentes de la especialidad en el país. #MejoresMédicos2026 #Neurología #LideresMexicanos #HospitalAngelesLomas #EsclerosisMúltiple

🕐 Enregistrement obligatoire du temps de travail à partir de 2027 : Votre maison de repos est-elle prête ? Inscrivez-vous au webinaire gratuit.

Meet us at ESMO Madrid booth #1076A Many sponsors still treat APAC as an afterthought in oncology development. The data suggests a different approach. We explore how integrating China and Japan early into global oncology programs can deliver meaningful enrolment acceleration, improve regulatory flexibility, and support faster proof-of-concept decisions In our latest article by Luke S. Gill, Head of Oncology, Will Chen, Global Head of Regulatory Affairs and Rokuya Nochi, Ph.D, MBA of EPS , learn how sponsors can unlock the full potential of APAC in oncology development. https://lnkd.in/etdah_GD #Oncology #ClinicalTrials #DrugDevelopment #China #Japan #APAC #Biotech #EmeraldClinicalESMOESMO - European Society for Medical Oncology

Most digital health platforms don't fail because of poor execution. They break at the fifth integration, when the team realizes the product has no shared definition of a patient. The numbers behind that moment are public. By 2025, 96% of US hospitals could send summary-of-care records electronically, and 94% could query outside sources. The share that integrates an incoming record into the EHR without manual entry: 79%, barely moved since 2022. Moving data turned out to be the solvable part. We wrote up what we keep seeing in platform projects: • Why point-to-point EHR integration stops scaling around the fourth source • The nine capabilities a data layer needs before any application is built on top • Six architectural shortcuts that buy a demo early and cost a rebuild later • Where assembling from ready components beats a custom build, and where it does not. Full article: https://lnkd.in/eQrefJgB What is the blocker on your side right now: terminology normalization, patient identity resolution, governance across tenants, or another EHR integration? Share your thoughts in the comments. #healthcaredata #FHIR #interoperability #digitalhealth #healthtech

In occasione della Giornata Mondiale dell'Osteoporosi, vogliamo dedicare una riflessione al valore della prevenzione e della cura della salute ossea. L'osteoporosi è una condizione caratterizzata dalla riduzione della robustezza dell'osso, con un conseguente aumento del rischio di fratture. Si tratta di un processo spesso silente, che può progredire senza segnali evidenti fino al manifestarsi delle prime complicanze. La prevenzione rappresenta lo strumento più efficace e si costruisce nel corso di tutta la vita: un'alimentazione equilibrata e ricca di calcio e vitamina D, un'attività fisica regolare e adeguata e uno stile di vita sano contribuiscono a preservare la densità ossea. Quando indicato, un controllo strumentale come la densitometria ossea consente di individuare precocemente eventuali fragilità e di orientare gli approfondimenti necessari. Promuovere la cultura della prevenzione significa tutelare la qualità della vita delle persone e accompagnarle verso un invecchiamento attivo e in salute. 📞 Per informazioni e prenotazioni: www.casacuratoniolo.it 📄 Nota legale: L. n. 175/1992, art. 4, c. 2 – Direttore sanitario: Dott.ssa Katiuscia Sponsano